AIC
PAVMZ

Ameritas Investment Company’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

Ameritas Investment Company’s Portfolio PAVMZ Stock Details PAVMZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-100
Closed – – 1817
2018
Q4 		$0 Buy
+100
New +$34 ﹤0.01% 1579

Other funds holding PAVMZ

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MRCM
M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return
LWAC
Laurel Wealth Advisors (California) Solana Beach, California $1.01B AUM 13.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameritas Investment Company's PAVMZ Position: Q1 2019 in Review

Ameritas Investment Company sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q1 2019, closing a stake of 100 shares.

Ameritas Investment Company first reported a position in PAVMZ in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 6 funds tracked by Wall St. Rank hold PAVMZ as of Q1 2019.

  • Ameritas Investment Company reported no remaining PAVmed Inc. Series Z Warrant position as of Q1 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 100 PAVmed Inc. Series Z Warrant shares in Q1 2019.
  • Ameritas Investment Company first reported a position in PAVmed Inc. Series Z Warrant in Q4 2018 and held it in 1 quarter.
  • Ameritas Investment Company's PAVmed Inc. Series Z Warrant position peaked at $0 in Q4 2018.
  • 6 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.